MC10 & UCB, Inc. Partner For Innovative Solutions For Patients With Neurological Disorders

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

CAMBRIDGE, Mass. & BRUSSELS--(BUSINESS WIRE)--Technology company MC10 Inc. and global biopharmaceutical company UCB announced that they have entered into a partnership to develop MC10’s Biostamp™ platform for patient-focused disease management solutions. The collaboration will evaluate the integration of MC10’s novel, conformal sensing platform with UCB’s pharmaceutical products to make a positive difference in the lives of people living with severe neurological disorders.

Help employers find you! Check out all the jobs and post your resume.

Back to news